계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Respirics
company
About
Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $3.40M
- Industries
- Biotechnology,Developer Platform,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 1 - 10
- Operating Status
- Close
Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products using the company's proprietary, customizable Acu-Breatheâ„¢ dry powder inhalers (DPIs). The company's strategy is to develop a suite of inhalation products for asthma and COPD, and to enter licensing and co-development programs with large or specialty pharmaceutical companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.40M
Respirics has raised a total of
$3.40M
in funding over 2 rounds. Their latest funding was raised on
Sep 27, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 27, 2005 | Series A | $3.40M | 1 |
Research Triangle Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Respirics is funded by 1 investors.
Research Triangle Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Research Triangle Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
